Form 4 for DTIL PRECISION BIOSCIENCES INC
Accepted 2025-03-25 00:00:00 ET · period of report 2025-03-21 · accession 0000950170-25-044599 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-03-25 | 2025-03-21 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | — | +3,417 | 110.5K | +3% | — |
| DT | 2025-03-25 | 2025-03-24 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $5.56 | -964 | 109.5K | -0.9% | -$5,360 |
| DT | 2025-03-25 | 2025-03-21 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | $0.00 | -3,417 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-21 | M | A | 3,417 | — | 110,504 | D | — | — | (F1) Represents the vesting of Restricted Stock Units ("RSUs") on March 21, 2025. (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
| 2 | Common | Common Stock | 2025-03-24 | S | D | 964 | $5.56 | 109,540 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-03-21 | M | D | 3,417 | $0.00 | 0 | D | — · — to — | 3,417 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. (F4) On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 21, 2025. |